CA1001635A - Derive de la l hydroxy-4 proline, sa preparation et les compositions medecinales qui le contiennent - Google Patents

Derive de la l hydroxy-4 proline, sa preparation et les compositions medecinales qui le contiennent

Info

Publication number
CA1001635A
CA1001635A CA186,521A CA186521A CA1001635A CA 1001635 A CA1001635 A CA 1001635A CA 186521 A CA186521 A CA 186521A CA 1001635 A CA1001635 A CA 1001635A
Authority
CA
Canada
Prior art keywords
hydroxy
preparation
compositions containing
medicinal compositions
proline derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA186,521A
Other languages
English (en)
French (fr)
Other versions
CA186521S (en
Inventor
Daniel Farge
Mayer N. Messer
Claude Moutonnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc SA filed Critical Rhone Poulenc SA
Application granted granted Critical
Publication of CA1001635A publication Critical patent/CA1001635A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
CA186,521A 1972-11-23 1973-11-22 Derive de la l hydroxy-4 proline, sa preparation et les compositions medecinales qui le contiennent Expired CA1001635A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7241639A FR2207702B1 (hr) 1972-11-23 1972-11-23

Publications (1)

Publication Number Publication Date
CA1001635A true CA1001635A (fr) 1976-12-14

Family

ID=9107588

Family Applications (1)

Application Number Title Priority Date Filing Date
CA186,521A Expired CA1001635A (fr) 1972-11-23 1973-11-22 Derive de la l hydroxy-4 proline, sa preparation et les compositions medecinales qui le contiennent

Country Status (19)

Country Link
JP (1) JPS504066A (hr)
AR (1) AR199319A1 (hr)
AU (1) AU473116B2 (hr)
BE (1) BE807684A (hr)
CA (1) CA1001635A (hr)
CH (1) CH576958A5 (hr)
DD (1) DD107455A5 (hr)
DE (1) DE2358470A1 (hr)
ES (1) ES420780A1 (hr)
FR (1) FR2207702B1 (hr)
GB (1) GB1397675A (hr)
HU (1) HU166917B (hr)
IL (1) IL43684A (hr)
LU (1) LU68846A1 (hr)
NL (1) NL7315685A (hr)
OA (1) OA04505A (hr)
SE (1) SE382453B (hr)
SU (1) SU507225A3 (hr)
ZA (1) ZA738874B (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1281288C (en) * 1984-11-05 1991-03-12 Wilhelm Hoerrmann Tumor therapy
JPS63218621A (ja) * 1987-03-09 1988-09-12 Kazuoki Tsuchiya 肥満症の予防・治療用組成物
US20080102042A1 (en) * 2004-10-28 2008-05-01 Kyowa Hakko Kogyo Co., Ltd. Oral Composition

Also Published As

Publication number Publication date
ZA738874B (en) 1974-10-30
BE807684A (fr) 1974-05-22
IL43684A0 (en) 1974-03-14
FR2207702A1 (hr) 1974-06-21
JPS504066A (hr) 1975-01-16
DE2358470A1 (de) 1974-05-30
CH576958A5 (hr) 1976-06-30
OA04505A (fr) 1980-03-30
IL43684A (en) 1976-06-30
SU507225A3 (ru) 1976-03-15
SE382453B (sv) 1976-02-02
FR2207702B1 (hr) 1975-11-28
AU473116B2 (en) 1976-06-10
ES420780A1 (es) 1976-04-01
AR199319A1 (es) 1974-08-23
HU166917B (hr) 1975-06-28
DD107455A5 (hr) 1974-08-05
NL7315685A (hr) 1974-05-27
LU68846A1 (hr) 1974-06-21
GB1397675A (en) 1975-06-18
AU6277173A (en) 1975-05-22

Similar Documents

Publication Publication Date Title
IL42430A0 (en) Pyridopyrrolobenzheterocycles,their preparation and pharmaceutical compositions containing them
CA1003752A (en) Pharmaceutical compositions
AU457015B2 (en) Piperidine derivatives, their preparation and compositions containing them
IL42429A0 (en) 2-alkoxycephalosporins,their preparation and pharmaceutical compositions containing them
AU475599B2 (en) Pharmaceutical compositions
CA991184A (fr) Derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
CA1001635A (fr) Derive de la l hydroxy-4 proline, sa preparation et les compositions medecinales qui le contiennent
IL43283A0 (en) Indoloquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL42613A0 (en) Amino-imidazo-and amino-pyrazolo-isoquinolines,their preparation and pharmaceutical compositions containing them
AU476390B2 (en) Pharmaceutical composition
IL40747A0 (en) 1-phenyl-3-hydroxy-3-methyl-triazenes,their preparation and pharmaceutical compositions containing them
AU464515B2 (en) Condensed bensopyran derivatives and pharmaceutical compositions containing them
AU5915973A (en) Pharmaceutical compositions
AU471794B2 (en) Iodophor-steroid pharmaceutical compositions
CA1006816A (fr) Compositions pharmaceutiques
IL42435A0 (en) Novel diaminoacridine derivatives,their preparation and pharmaceutical compositions containing them
CA907518A (en) Medicinal compositions
CA851190A (en) Sulphonyl-ureas and sulphonyl-semicarbazides, preparation thereof and pharmaceutical compositions
CA904751A (en) Pharmaceutical compositions and their preparation
CA992959A (en) O-triazenobenzamides, compositions, use and preparation thereof
AU477696B2 (en) Doxycyoline-containing pharmaceutical composition and preparation thereof
CA904864A (en) N,n'-dihalomethyl phenobarbital compounds and therapeutic compositions containing same
CA900356A (en) Pharmaceutical compositions
CA896528A (en) Pharmaceutical compositions
CA910906A (en) Pharmaceutical compositions